Literature DB >> 32053285

Prolonged survival after disseminated Rhinocladiella infection treated with surgical excision and posaconazole.

Nicola Hardman1, Nicola Young1, Richard Hobson1, Jonathan Sandoe1, Matthew Wellberry-Smith2, Simon Thomson3, Richard Barton4.   

Abstract

Cerebral abscess due to pigmented molds is a rare but usually fatal infection occasionally seen in transplant recipients. A 67-year-old man of Iraqi origin underwent a deceased donation renal transplant for renal failure and 2 months later was diagnosed with an abscess in the left posterior frontal lobe of his brain. Subsequent biopsy proved this to be due to the mold Rhinocladiella mackenziei. Further interventions included two operations to aspirate the lesion, voriconazole, then liposomal amphotericin B, then a combination of posaconazole and flucytosine which he continued for over 4 years. He also suffered from right ankle pain and was diagnosed with septic arthritis; R mackenziei was isolated from pus aspirated from the ankle joint. He responded well to the treatment and has had little loss of function, and on CT, the cerebral lesion has stabilized. Beta-D-glucan, initially at very high levels proved useful to monitor response over the 5 years and the latest sample was negative (38 pg/mL). This case is notable for the first disseminated case of this infection, its favorable outcome on a novel antifungal combination and a new approach to monitoring the course of disease.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Rhinocladiella; beta-D-glucan; brain abscess; disseminated; excision; fungal

Year:  2020        PMID: 32053285     DOI: 10.1111/tid.13264

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  1 in total

1.  Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in an immunocompetent patient: A case report and review of literature.

Authors:  Muhammad Zain Mushtaq; Saad Bin Zafar Mahmood; Nosheen Nasir; Malik Saad Rashid; Memoona Irshad; Kiren Habib; Iffat Khanum
Journal:  Curr Med Mycol       Date:  2020-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.